Pediatric Exclusivity Granted July 2014 (No Recent Changes)

Transcription

Pediatric Exclusivity Granted
July 2014
(No Recent Changes)
Drug
Date of
Exclusivity
Sponsor
Indication(s)
1.
Abacavir
12/14/98
Glaxo
HIV
2.
Albuterol
8/27/08
GSK
Treatment and prevention of bronchospasm in children
from birth to <4 years of age with obstructive airway
disease
3.
Alendronat
e
4/28/03
Merck
Osteogenesis imperfecta
4.
Alfuzosin
9/7/10
Sanofi
Aventis
Treatment of patients 2 - 16 yrs with elevated
detrusor leak point pressure associated with a
known neurological disorder (e.g., spina bifida)
5.
Almotriptan
1/13/09
Acute treatment of migraine headache in adolescents,
ages 12 to 17 years
6.
Amlodipin
e
Ammoniu
m Lactate
Amphetam
ine Mixed
Salts
Anagrelide
11/27/01
Johnson &
Johnson
Pfizer
Ichthyosis vulgaris candidiasis
10/28/04
WestwoodSquibb
Shire
5/25/04
Shire
10.
Anastrozol
e
11/14/07
AstraZeneca
Thrombocythemia secondary to
myeloproliferative disorders
Male pubertal patients with gynecomastia and
female pediatric patients with McCune-Albright
syndrome with progressive precocious puberty.
11.
11/14/07
Otsuka
Schizophrenia; Bipolar Depression
12/18/01
Lilly
Attention Deficit Hyperactivity Disorder
2/22/02
Pfizer
Hypercholesterolemia
8/6/03
GSK
Prevention of Malaria
15.
Aripiprazol
e
Atomoxeti
ne
Atorvastati
n
Atovaquon
e/
Proguanil
Azelastine
8/11/99
Asta
Itching associated with allergic conjunctivitis
16.
Balsalazide 8/23/06
Salix
Ulcerative colitis
17.
Benazepril
Novartis
Hypertension
7.
8.
9.
12.
13.
14.
10/1/99
7/2/03
Hypertension
ADHD
Drug
18.
Date of
Exclusivity
Sponsor
Indication(s)
Bendamust
ine
Betaxolol
**
(effective
6/07 when
it rev’d
HW exclu)
5/24/12
Cephalon
Relapsed or refractory acute leukemia
2/28/07
Falcon
Treatment of elevated intraocular pressure
20.
Bicalutamid
e
9/19/08
AstraZeneca
Treatment of gonadotropin-independent precocious
puberty in boys with testotoxicosis
21.
Bisoprolol
4/19/00
Lederle
Hypertension
22.
Bivalirudin
6/17/09
The
Medicines
Company
Use as an anticoagulant in children during
percutaneous
intravascular procedures for the management of
congenital heart disease
23.
10/10/01
Allergan
Lower intraocular pressure
6/28/06
Alcon
11/12/02
AstraZeneca
Asthma & allergic rhinitis
26.
Brimonidin
e
Brinzolami
de
Budesonid
e
Buspirone
5/22/00
Bristol-Myers
Generalized anxiety disorder
27.
Busulfan
3/12/02
28.
Calcitriol
2/16/01
Orphan
Medical
Abbott
Conditioning regimen for allogeneic bone marrow
transplant
Hypocalcemia management in patients on
hemodialysis
29.
Candesartan
7/20/09
AstraZeneca
Reduce blood pressure
30.
Capecitabi
ne
Carboplati
n
Carvedilol
8/28/13
4/30/04
Hoffman-La
Roche
BMS
Non-disseminated intrinsic diffuse brain stem
gliomas
Refractory tumors
11/8/06
GSK
Heart failure
33.
Caspofungi
n
4/15/08
Merck & Co
Fungal Infections
34.
Celecoxib
8/23/06
Pfizer
JRA
35.
Cetirizine
3/13/02
Pfizer
Allergic rhinitis/urticaria
36.
Ciprofloxa
cin
Ciprofloxa
cin Ophth
12/18/03
Bayer
Complicated UTI, Acute pyelonephritis
1/10/03
Alcon
Bacterial conjunctivitis
19.
24.
25.
31.
32.
37.
Drug
Date of
Exclusivity
Sponsor
Indication(s)
38.
Citalopram
7/12/02
Forest
Depression
39.
Clofarabin
e
7/14/04
Ilex
Refractory Leukemias
40.
Clopidogrel
1/20/11
Sanofi
Aventis
41.
Colesevela
m
2/17/09
42.
11/2/99
43.
Cromolyn
Sodium
Darunavir
6/7/11
Daiichi
Sankyo
Pharmacia &
Upjohn
Tibotec
Reduction of the incidence of thrombosis in children
with systemic to pulmonary artery shunts for palliation
of cyanotic congenital heart disease
Treatment of patients diagnosed with heterozygous
familial hypercholesterolemia (heFH)
44.
Desflurane
9/13/06
Baxter
Anesthesia
45.
Desloratadi 2/12/03
ne
Dexmedeto 3/12/13
midine
Schering
Hospira
47.
Didanosine 8/13/01
Bristol-Myers
Loading and maintenance infusion for sedation in
intubated and mechanically ventilated pediatric
patients
Treatment of HIV
48.
Diflupredna
te
3/21/13
Alcon
Treatment of post-operative inflammation following
cataract surgery
49.
Docetaxel
3/17/10
Solid Tumors
50.
1/5/04
51.
Dorzolami
de
Duloxetine
Sanofi
Aventis
Merck
7/2/12
Eli Lilly
Major depressive disorder (MDD)
52.
Efavirenz
1/29/13
BMS
Treatment of HIV-1
53.
5/24/06
Gilead
Treatment of HIV-1
54.
Emtricitabi
ne
Enalapril
2/2/00
Merck
Hypertension
55.
Entecavir
12/5/13
BMS
Chronic Hepatitis B Virus Infection
56.
Eplerenone 10/24/07
Pfizer
Hypertension
57.
Ertapenem
2/11/05
Merck
58.
Esmolol
8/22/03
Baxter
Meningitis; hospital acquired pneumonia, intraabdominal infection, or acute pelvic infection;
CAP, cUTI, or skin and soft tissue infection
Hypertension
59.
Esomeprazo
le**
5/1/09
AstraZeneca
Treatment of gastroesophageal reflux disease (GERD)
60.
Eszopiclon
6/29/12
Sunovion
Insomnia in children with ADHD
46.
Allergic rhinitis
Treatment of HIV
Reduction in intraocular pressure
Drug
Date of
Exclusivity
Sponsor
Indication(s)
e
61.
Etodolac
62.
Wyeth Ayerst
Juvenile Rheum/Arthritis
Everolimus 7/10/12
Novartis
63.
Ezetimibe
2/14/08
64.
Famciclovir
9/21/09
MSP
Singapore
Novartis
Treatment of patients with tuberous sclerosis
complex (TSC) who have subependymal giant
cell astrocytoma (SEGA)
Heterozygous familial
hypercholesterolemia
65.
Famotidine 11/21/00
Merck
Gastro-esophageal reflux
66.
Felodipine
8/30/01
Astra Zeneca
Hypertension
67.
Fentanyl
1/29/03
Alza
Chronic pain
68.
1/27/03
Aventis
1/21/04
Pfizer
Tinea capitis
4/3/03
Berlex
Refractory/relapse acute leukemia
71.
Fexofenadi
ne
Fluconazol
e
Fludarabin
e
Fluoxetine
11/15/00
Lilly
Depression & Obsessive Compulsive Disorder
72.
Fluticasone 2/25/03
GSK
Asthma & atopic dermatitis
73.
Fluvastatin
12/15/05
Novartis
74.
1/3/00
Solvay
1/10/12
ViiV
HIV
76.
Fluvoxami
ne
Fosampren
avir
Fosinopril
Familial
Obsessive Compulsive Disorder
1/27/03
Hypertension
77.
Fulvestrant
2/1/11
Bristol-Myers
Squibb
AstraZeneca
78.
Gabapentin 2/2/00
Parke Davis
79.
Gatifloxacin 5/19/09
Allergan
Treatment of bacterial conjunctivitis in peds 0 - 1
month of age
80.
Gemcitabin 1/27/05
e
Glimepirid 6/9/05
e
Glyburide/ 10/8/03
Metformin
Lilly
Aventis
Refractory or relapsed leukemia and nonHodgkin’s lymphoma
Type II Diabetes
BMS
Diabetes Mellitus
69.
70.
75.
81.
82.
12/6/99
Treatment of children 1 month – 12 years of age w/
herpes simplex (HSV) & 1 – 12 years w/ varicella
zoster (VSV)
Treatment of progressive precocious puberty in
girls with McCune-Albright Syndrome
Epilepsy
Drug
Date of
Exclusivity
Sponsor
Indication(s)
/**
83.
Ibuprofen
7/1/98
McNeil
Fever, aches/pains cold symptoms
84.
Ibuprofen*
*
Ibuprofen/
pseudoeph
edrine
Imatinib
Mesylate
Imiquimod
7/1/98
Whitehall
Fever, aches/pains cold symptoms
9/19/01
Whitehall
Cold, flu, sinus symptoms
6/9/06
Novartis
Philadelphia positive (Ph+) leukemia
12/13/06
3M
Molluscum contagiosum
85.
86.
87.
88.
90.
Insulin
5/24/05
Aspart
Recombina
nt
Insulin
7/12/99
Glargine
Irbesartan
9/16/04
91.
Irinotecan
92.
Isotretinoin 6/12/01
93.
Ixabepilon
e
Ketorolac
4/5/11
SanofiSynthelabo
Pharmacia &
Upjohn
Hoffman-La
Roche
BMS
9/6/01
Allergan
Itching associated with allergic conjunctivitis
Lamivudin
e
Lamivudin
e**
Lamotrigin
e
9/22/00
Glaxo
HIV
7/25/01
Glaxo/SK
Hepatitis B
2/14/07
GSK
Partial seizures
98.
Lansoprazol
e
7/15/08
Treatment of Gastroesophageal Reflux Disease
(GERD)
99.
Leflunomi
de
11/10/03
Tap
Pharmaceutic
al Products,
Inc.
Aventis
100.
Levetiraceta
m
6/3/08
UCB Inc.
Partial seizures
101.
Levobetax
olol
6/28/06
Alcon
89.
94.
95.
96.
97.
3/10/04
Novo Nordisk Type I Diabetes
Aventis
Diabetes Mellitus
Hypertension
Refractory tumors
Severe recalcitrant nodular acne
Solid Tumors
JRA
Drug
Date of
Exclusivity
8/25/09
Sponsor
Indication(s)
102.
Levocetirizi
ne
103.
Ortho McNeil Community acquired pneumonia
104.
Levofloxac 3/14/07
in
Linezolid
2/11/05
105.
Lisinopril
11/19/01
Astra Zeneca
Skin and skin structure infections; suspected
resistant gram positive infections; VRE
infections; CSF shunts
Hypertension
106.
Lisinopril
11/19/01
Merck
Hypertension
107.
3/7/08
Abbott
HIV
108.
Lopinavir/
Ritonavir§
Loratadine
8/14/00
Schering
109.
Losartan
3/20/02
Merck
Hypertension
110.
Bausch &
Lomb
Treatment of superficial bacterial ocular infection
111.
Lotepredno 12/28/10
l/Tobramyc
in
Lovastatin 7/17/01
Merck
112.
Meloxicam 4/15/05
JRA
113.
Memantine 6/16/14
Boehringer
Ingelheim
Forest Labs
114.
Metformin
3/15/00
Bristol-Myers
Diabetes Mellitus
115.
12/4/03
McNeil
ADHD
116.
Methylphe
nidate
Metoprolol
7/27/06
AstraZeneca
Hypertension
117.
Midazolam 9/18/98
Sedation/anxiolysis Amnesia
118.
Milrinone
9/24/01
119.
Modafinil
3/21/06
Hoffman-La
Roche
SanofiSythelabo
Cephalon
120.
Mometaso
ne
Monteluka
st
Moxifloxac
in Ophth
Nabumeton
e
Nefazodon
e
11/7/01
Schering
12/10/01
Merck
Corticosteroid responsive dermatoses/ Allergic
rhinitis
Asthma
1/10/03
Alcon
8/30/01
Glaxo/SK
6/27/02
Bristol-Myers
Depression
121.
122.
123.
124.
UCB
Pharmacia
Upjohn
Treatment of allergic rhinitis and urticaria in children
6 months to < 6 years of age
Autism & Autism Spectrum Disorder (ASD)
Prevent heart failure after cardiopulmonary
bypass
Narcolepsy
Drug
Date of
Exclusivity
Sponsor
Indication(s)
125.
Nelfinavir
9/4/03
Agouron
HIV
126.
Nevirapine
12/17/01
Perinatal transmission of HIV infection
127.
Nitric
Oxide
11/2/10
Boehringer
Ingelheim
INO
Therapeutics
128.
Johnson &
Johnson
129.
Norgestima 12/18/03
te/ ethinyl
estradiol
Octreotide 1/12/06
Novartis
Hypothalamic obesity
130.
Ofloxacin
Allergan
131.
Olanzapine 1/10/07
Lilly
Adolescent-Onset Bipolar disorder and
Adolescent-Onset Schizophrenia
132.
Olmesartan
10/7/09
Treatment of hypertension in pediatric patients 1 – 16
years of age
133.
Olopatadine
8/12/09
Daiichi
Sankyo
Alcon
134.
Omeprazol 5/1/01
e
Ondansetro 12/1/04
n
Orlistat
9/12/03
Astra Zeneca
Glaxo
Nausea
Roche
Obesity
Roche
Influenza A & B
138.
Oseltamivi 3/22/04
r
Oxaliplatin 9/27/06
Refractory tumors
139.
Oxaprozin
12/6/99
SanofiAventis
Searle
140.
Oxcarbaze
pine
Oxybutyni
n
3/2/05
Novartis
Partial seizures
2/8/02
Alza
Detrusor hyperreflexia
Treatment of adolescent schizophrenia
135.
136.
137.
141.
3/12/03
142.
Paliperidone 1/5/11
143.
Palonosetro
n
4/10/14
OrthoMcNeilJanssen
Helsinn
144.
Pantoprazol
e
2/17/09
Wyeth
Provide ventilatory assistance to preterm neonates
with respiratory distress and reduce the risk of
chronic lung disease (CLD) in preterm neonates
at high risk of developing CLD
Bone mineral density in anorexia nervosa patients
Allergic rhinitis
Prevention of postoperative nausea and vomiting
(PONV) and chemotherapy induced nausea and
vomiting (CINV)
Short-term treatment of Symptomatic GERD in
pediatric patients
Drug
Date of
Exclusivity
Sponsor
Indication(s)
145.
Paricalcitol 12/8/03
Abbott
End Stage Renal Disease
146.
Paroxetine
6/27/02
GlaxoSK
Depression & OCD
147.
Pemetrexe
d
12/3/10
Eli Lilly
148.
Pemirolast
8/11/99
Santen
Treatment of pediatric patients with refractory
and recurrent solid tumors, including
osteosarcoma, Ewing sarcoma/peripheral PNET,
rhabdomyosarcoma, and neuroblastoma
Allergic conjunctivitis
149.
Novartis
Atopic dermatitis
150.
Pimecrolim 9/24/01
us
Pravastatin 7/10/02
Bristol-Myers
151.
Propofol
8/11/99
Zeneca
Anesthetic
152.
Quetiapine
1/23/09
AstraZeneca
Treatment of schizophrenia and bipolar mania in
pediatric patients
153.
Quinapril
6/7/02
Parke-Davis
Hypertension
154.
Rabeprazol 12/4/12
e
Eisai
155.
Ranitidine
Glaxo
Healing & maintenance of healing of GERD &
improvement of GERD symptoms in children 1 to
11 years of age
156.
Remifentan 3/15/00
il
Ribavirin/I 5/9/01
ntron A
Abbott
Anesthetic
Schering
Chronic Hepatitis C
158.
Risedronate
4/24/09
Procter &
Gamble
Prevent vertebral and non-vertebral fractures in
children with moderate-to-severe
osteogenesis imperfecta (OI)
159.
2/28/07
Janssen
160.
Risperidon
e
Ritonavir
6/14/05
Abbott
Adolescent-Onset Schizophrenia; Bipolar
Disorder
HIV
161.
Rizatriptan
9/20/11
Merck
Migraine headaches
162.
Rocuronium 4/3/08
Organon
Anesthesia
163.
Rofecoxib
Merck
JRA
164.
Rosiglitazo 12/9/04
ne
SB Pharmco
Type II Diabetes
165.
Rosuvastati
n
7/7/09
AstraZeneca
Adjunct to diet to reduce cholesterol and ApoB levels
in children 10-17 years of age
166.
Salmeterol
3/9/06
GSK
Asthma
157.
1/19/99
2/18/04
Drug
167.
Sapropterin
Date of
Exclusivity
3/13/14
168.
Saquinavir
10/26/10
169.
Sertraline
2/1/02
Hoffman-La
Roche Inc.
Pfizer
170.
Sevofluran
e
Sibutramin
e
Sildenafil
8/2/00
Abbott
Anesthetic
10/6/04
Abbott
Pediatric Obesity
2/9/12
Pfizer
Simvastati
n
Sirolimus
2/22/02
Merck
Treatment of pulmonary arterial hypertension
(PAH)
11/17/04
Wyeth
Prevention of organ rejection following renal
transplantation
Watson
Iron deficiency due to chronic hemodialysis
1/6/00
Berlex Lab
Arrhythmias
171.
172.
173.
174.
175.
BioMarin
Indication(s)
Treatment to reduce blood phenylalanine (Phe) levels
in patients with hyperphenylalaninemia
(HPA) due to BH4-responsive phenylketonuria (PKU)
Treatment of HIV infection in pediatric patients in
combination with other antiretroviral agents
Depression
176.
Sodium
ferric
gluconate
complex
Sotalol
177.
Stavudine
8/13/01
Bristol-Myers
HIV
178.
2/18/04
GSK
Migraine
179.
Sumatripta
n
Tamoxifen
5/16/02
AstraZeneca
McCune-Albright Syndrome
180.
Tamsulosin
9/17/09
Boehringer
Ingelheim
Treatment of 2 – 16 year olds w/ elevated detrusor
leak point pressure associated w/ a known
neurological disorder (e.g., spina bifida)
181.
1/11/08
BMS
Kawasaki’s disease
11/20/02
Schering
Refractory/relapse malignancies
2/28/12
Pfizer
Treatment of relapsed/refractory solid tumors
184.
Technetiu
m Tc99
sestamibi
Temozolo
mide
Temsirolim
us
Tenofovir
9/6/11
Gilead
HIV
185.
Terbinafine 12/4/06
Novartis
Tinea capitis
186.
Testosteron 8/22/07
e
Unimed
Pharmaceutic
als,
Delayed onset of puberty in boys
182.
183.
3/24/04
Sponsor
Drug
Date of
Exclusivity
Sponsor
Indication(s)
187.
Timolol
2/28/07
Alcon
188.
Tipranavir
3/7/08
HIV
189.
Tolterodine 1/5/04
Boehringer
Ingelheim
Pfizer
190.
Topiramate
7/24/08
191.
Topotecan
11/20/02
OrthoMcNeilJanssen
Pharmaceutic
als, Inc.
GlaxoSK
- Mono- and adjunctive therapy for partial onset
or primary generalized tonic-clonic seizures
(epilepsy)
- Adjunctive therapy for seizures associated w/
Lennox-Gastaut syndrome
Refractory/relapse malignancies
192.
Tramadol
4/19/00
R.W. Johnson Post-surgical pain
193.
Valacyclov 2/26/08
ir
GSK
Herpes simplex virus infection
194.
Valganciclo
vir
7/24/08
195.
Valproic
acid
Valsartan
12/14/07
Hoffman-La
Roche Inc.
Abbott
Treatment & prevention of Cytomegalovirus
(CMV) Disease
Migraine, Bipolar disorder, Epilepsy
8/8/07
Novartis
Hypertension
Venlafaxin
e
Vigabatrin
12/2/02
Wyeth-Ayerst Depression/ OCD
10/3/13
Lundbeck
Vinorelbin
e
Zoledronic
acid
Zolmitripta
n
Zolpidem
8/15/02
GSK
Intractable Complex Partial Seizures & Infantile
Spasm
Leukemia/lymphoma
12/21/07
Novartis
Severe osteogenesis imperfecta
12/18/03
AstraZeneca
Migraine
196.
197.
198.
199.
200.
201.
202.
11/20/06
Detrusor hyperreflexia/ overactive bladder
Sanofi
Insomnia
Aventis
 This is the first period of Pediatric Exclusivity for glyburide and a second period for
metformin.
§ This is the first period of Pediatric Exclusivity for lopinavir and a second period for ritonavir.
** A second period of Pediatric Exclusivity was granted for this moiety.

Pediatric Exclusivity Granted July 2014 (No Recent Changes)

Transcription

Similar documents